X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3361) 3361
Publication (187) 187
Newsletter (80) 80
Book Review (54) 54
Book Chapter (36) 36
Newspaper Article (28) 28
Magazine Article (12) 12
Dissertation (5) 5
Book / eBook (2) 2
Conference Proceeding (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
levetiracetam (3159) 3159
epilepsy (1648) 1648
humans (1577) 1577
clinical neurology (1413) 1413
index medicus (1373) 1373
piracetam - analogs & derivatives (1162) 1162
male (1094) 1094
anticonvulsants - therapeutic use (1019) 1019
female (1015) 1015
seizures (984) 984
antiepileptic drugs (793) 793
piracetam - therapeutic use (685) 685
adult (677) 677
neurosciences (603) 603
neurology (588) 588
anticonvulsants (564) 564
middle aged (551) 551
epilepsy - drug therapy (533) 533
anticonvulsants - adverse effects (500) 500
pharmacology & pharmacy (483) 483
treatment outcome (477) 477
animals (467) 467
double-blind (426) 426
efficacy (402) 402
adolescent (386) 386
children (384) 384
analysis (365) 365
anticonvulsants - administration & dosage (357) 357
aged (354) 354
lamotrigine (352) 352
piracetam - adverse effects (347) 347
drug therapy (342) 342
child (341) 341
psychiatry (330) 330
status epilepticus (313) 313
anticonvulsants - pharmacology (306) 306
phenytoin (306) 306
topiramate (296) 296
piracetam - administration & dosage (288) 288
carbamazepine (278) 278
dose-response relationship, drug (277) 277
seizures - drug therapy (271) 271
pharmacokinetics (267) 267
care and treatment (262) 262
piracetam - pharmacology (259) 259
pediatrics (254) 254
rats (252) 252
electroencephalography (239) 239
tolerability (238) 238
young adult (238) 238
retrospective studies (237) 237
drugs (233) 233
research (228) 228
antiepileptic drug (215) 215
drug therapy, combination (212) 212
brain (204) 204
medicine & public health (202) 202
dosage and administration (196) 196
valproic acid (193) 193
antiepileptic drug levetiracetam (191) 191
monotherapy (174) 174
risk factors (173) 173
child, preschool (170) 170
behavioral sciences (167) 167
therapy (166) 166
epilepsies, partial - drug therapy (165) 165
multicenter (164) 164
refractory partial seizures (163) 163
partial seizures (161) 161
valproate (161) 161
complications and side effects (159) 159
oxcarbazepine (157) 157
safety (157) 157
health aspects (155) 155
medical research (154) 154
partial-onset seizures (150) 150
anticonvulsants - pharmacokinetics (149) 149
seizure (146) 146
disease models, animal (145) 145
management (145) 145
etiracetam (143) 143
gabapentin (143) 143
medicine, experimental (141) 141
mice (138) 138
refractory epilepsy (136) 136
prospective studies (135) 135
add-on therapy (134) 134
trial (134) 134
aged, 80 and over (133) 133
placebo-controlled trial (132) 132
status epilepticus - drug therapy (132) 132
convulsions & seizures (131) 131
follow-up studies (129) 129
temporal-lobe epilepsy (121) 121
adults (119) 119
profile (119) 119
surgery (119) 119
ucb l059 (118) 118
intravenous levetiracetam (117) 117
eeg (115) 115
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3198) 3198
Italian (109) 109
Spanish (65) 65
German (49) 49
Russian (44) 44
French (24) 24
Turkish (10) 10
Japanese (9) 9
Hungarian (5) 5
Korean (3) 3
Czech (2) 2
Bosnian (1) 1
Chinese (1) 1
Croatian (1) 1
Danish (1) 1
Persian (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain Injury, ISSN 0269-9052, 2016, Volume 30, Issue 5-6, pp. 682 - 683
Journal Article
International journal of pharmaceutical compounding, ISSN 1092-4221, 03/2017, Volume 21, Issue 2, pp. 127 - 130
Three-dimensional printing quickly became a standard tool in the automotive, aerospace, and consumer goods industries and, recently, has begun gaining traction... 
Journal Article
The Journal of Maternal-Fetal & Neonatal Medicine, ISSN 1476-7058, 12/2019, Volume 32, Issue 24, pp. 4093 - 4096
Objective: To evaluate levetiracetam (LEV) efficacy in preterm infants admitted in NICU. Study design: Clinical characteristics of 26 preterm infants treated... 
neonatal intensive care | premature | Levetiracetam
Journal Article
Epilepsy Research, ISSN 0920-1211, 10/2019, p. 106214
Journal Article
Epilepsy & Behavior, ISSN 1525-5050, 11/2019, Volume 100, p. 106344
While levetiracetam (LEV) usage is a known risk factor for psychosis in epilepsy, the modulating effect of certain patient and treatment characteristics on the... 
Psychosis | AIPD | Epilepsy | Psychotic symptoms | Levetiracetam
Journal Article
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 08/2018, Volume 121, pp. 29 - 33
Selective receptors imaging using gamma emitting radiopharmaceuticals allows accurate diagnosis and follow up of many brain related disorders. Levetiracetam, a... 
Receptor imaging | Radiopharmaceuticals | Microemulsion | Levetiracetam
Journal Article
Turkiye Klinikleri Pediatri, ISSN 1300-0381, 2019, Volume 28, Issue 1, pp. 51 - 54
Journal Article
Netherlands Journal of Critical Care, ISSN 1569-3511, 2015, Volume 20, Issue 2, pp. 29 - 32
Journal Article
Epilepsy & Behavior, ISSN 1525-5050, 01/2018, Volume 78, pp. 194 - 201
Brivaracetam is a new antiepileptic drug indicated for adjunctive treatment of focal seizures in adults at a dose of 50–200 mg/day taken in two equal doses.... 
Antiepileptic drug | Alprazolam | Subjective measures | Brivaracetam | Abuse potential | Levetiracetam | SAFETY | PSYCHIATRY | CLINICAL NEUROLOGY | PARTIAL-ONSET SEIZURES | LIABILITY ASSESSMENT | CNS PHARMACODYNAMICS | PHARMACOKINETICS | DOUBLE-BLIND | BEHAVIORAL SCIENCES | PLACEBO-CONTROLLED TRIAL | ADJUNCTIVE BRIVARACETAM | ADVERSE EVENT PROFILE | Hypnotics and Sedatives - adverse effects | Central Nervous System Depressants - adverse effects | Humans | Middle Aged | Hypnotics and Sedatives - administration & dosage | Anticonvulsants - administration & dosage | Male | Anticonvulsants - pharmacology | Levetiracetam - adverse effects | Central Nervous System Depressants - pharmacology | Pyrrolidinones - administration & dosage | Young Adult | Anticonvulsants - adverse effects | Alprazolam - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Pyrrolidinones - pharmacology | Adult | Female | Alprazolam - pharmacology | Pyrrolidinones - adverse effects | Double-Blind Method | Alprazolam - adverse effects | Levetiracetam - administration & dosage | Street Drugs - adverse effects | Cross-Over Studies | Euphoria | Adolescent | Central Nervous System Depressants - administration & dosage | Levetiracetam - pharmacology | Hypnotics and Sedatives - pharmacology | Drug abuse | Anticonvulsants | Seizures (Medicine) | Analysis | Central nervous system
Journal Article
Profiles of Drug Substances, Excipients and Related Methodology, ISSN 1871-5125, 2019, Volume 44, p. 167
A comprehensive profile of levetiracetam is presented in this chapter which includes its description, formula, elemental analysis, appearance, uses and... 
Description | Stability | Physical characteristics | Pharmacokinetics study | Methods of synthesis | Methods of analysis | Levetiracetam | Levetiracetam - chemistry | Drug Stability | Levetiracetam - pharmacology
Journal Article
Pharmacotherapy, ISSN 0277-0008, 11/2001, Volume 21, Issue 11, pp. 1375 - 1388
Levetiracetam is a new antiepileptic drug, structurally and mechanistically dissimilar to other marketed antiepileptic drugs. It is effective in reducing... 
levetiracetam
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.